BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 102 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $28,000 | -56.9% | 9,999 | -18.6% | 0.00% | – |
| Q4 2021 | $65,000 | -74.7% | 12,286 | -59.5% | 0.00% | – |
| Q3 2021 | $257,000 | -32.9% | 30,321 | -3.4% | 0.00% | – |
| Q2 2021 | $383,000 | -42.3% | 31,395 | +14.7% | 0.00% | -100.0% |
| Q1 2021 | $664,000 | -24.3% | 27,363 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $877,000 | +6.0% | 27,363 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $827,000 | +7.0% | 27,363 | +49.2% | 0.00% | 0.0% |
| Q2 2020 | $773,000 | +68.8% | 18,341 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $458,000 | – | 18,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,014,858 | $17,046,000 | 0.60% |
| NEA Management Company, LLC | 3,449,845 | $29,186,000 | 0.35% |
| MPM BioImpact LLC | 248,506 | $2,102,000 | 0.33% |
| Artal Group S.A. | 1,646,517 | $13,930,000 | 0.31% |
| RA Capital Management | 2,589,904 | $21,911,000 | 0.30% |
| Bellevue Group AG | 3,463,000 | $29,297,000 | 0.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 760,128 | $6,431,000 | 0.13% |
| Ikarian Capital, LLC | 150,484 | $1,272,000 | 0.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,000 | $371,000 | 0.09% |
| Virtus ETF Advisers LLC | 16,600 | $140,000 | 0.06% |